413
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Analyzing research trends on drug safety using topic modeling

Pages 629-636 | Received 23 Jan 2018, Accepted 15 Mar 2018, Published online: 06 Apr 2018

References

  • Edwards IR, Bencheikh RS. Pharmacovigilance is… Vigilance. Drug Saf. 2016;39(4):281–285.
  • Murphy K. Machine learning: a probabilistic perspective. Cambridge, MA: The MIT Press; 2012.
  • Jensen LJ, Saric J, Bork P. Literature mining for the biologist: from information retrieval to biological discovery. Nat Rev Genet. 2006;7(2):119–129.
  • Griffiths TL, Steyvers M. Finding scientific topics. Proc Natl Acad Sci USA. 2004;101(Suppl 1):5228–5235.
  • Blei DM. Probabilistic topic models. Commun ACM. 2012;55(4):77–84.
  • Liu L, Tang L, Dong W, et al. An overview of topic modeling and its current applications in bioinformatics. Springerplus. 2016;5(1):1608.
  • Wang SH, Ding Y, Zhao W, et al. Text mining for identifying topics in the literatures about adolescent substance use and depression. BMC Public Health. 2016;16:279.
  • Sing DC, Metz LN, Dudli S. Machine learning-based classification of 38 years of spine-related literature into 100 research topics. Spine (Phila Pa 1976). 2017;42(11):863–870.
  • Hahn A, Mohanty SD, Manda P. What’s Hot and What’s Not? - exploring trends in bioinformatics literature using topic modeling and keyword analysis. In: Cai Z, Daescu O, Li M, editor. Bioinformatics research and applications. ISBRA 2017. Lecture Notes in Computer Science. Cham: Springer
  • Syed S, Weber CT. Using machine learning to uncover latent research topics in fishery models. Rev Fish Sci Aquaculture. 2018;1–18.
  • Arun R, Suresh V, Veni Madhavan CE, et al. On finding the natural number of topics with latent dirichlet allocation: some observations. In: Zaki MJ, Yu JX, Ravindran B, et al., editor. Advances in knowledge discovery and data mining. PAKDD 2010. Lecture Notes in Computer Science. Berlin, Heidelberg: Springer.
  • Zhao W, Chen JJ, Perkins R, et al. A heuristic approach to determine an appropriate number of topics in topic modeling. BMC Bioinf. 2015;16(Suppl 13):S8.
  • Jiang HC, Qiang MS, Lin P. A topic modeling based bibliometric exploration of hydropower research. Renewable Sustainable Energy Rev. 2016;57:226–237.
  • Suominen A, Toivanen H. Map of science with topic modeling: comparison of unsupervised learning and human-assigned subject classification. J Assoc Inf Sci Technol. 2016;67(10):2464–2476.
  • Feuerriegel S, Ratku A, Neumann D Analysis of how underlying topics in financial news affect stock prices using latent dirichlet allocation. 49th Hawaii International Conference on System Sciences (HICSS); Koloa, HI; 2016. p. 1072–1081.
  • Llewellyn C, Grover C, Oberlander J Summarizing newspaper comments. Proceedings of the Eighth International Conference on Weblogs and Social Media. ICWSM; 2014. p. 599–602.
  • Hengchen S, Coeckelbergs M, Van Hooland S, et al. Exploring archives with probabilistic models: topic modelling for the valorisation of digitised archives of the European Commission. IEEE International Conference on Big Data (Big Data); Washington, DC; 2016. p. 3245–3249.
  • Pearson SA, Pesa N, Langton JM, et al. Studies using Australia’s pharmaceutical benefits scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013). Pharmacoepidemiol Drug Saf. 2015;24(5):447–455.
  • World Health Organization Safety Monitoring of Medicinal Products. The Importance of Pharmacovigilance. Geneva: World Health Organization; 2002.
  • Council for International Organizations of Medical Sciences (CIOMS) Working Group IV. Benefit-risk balance for marketed drugs: evaluating safety signals. Geneva: CIOMS. 1998.
  • Arnaud M, Bégaud B, Thurin N, et al. Methods for safety signal detection in healthcare databases: a literature review. Expert Opin Drug Saf. 2017;16(6):721–732.
  • Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016;14:10.
  • Onakpoya IJ, Heneghan CJ, Aronson JK. Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis. Crit Rev Toxicol. 2016;46(6):477–489.
  • Hernandez JF, Mantel-Teeuwisse AK, Van Thiel GJ, et al. Publication trends in newspapers and scientific journals for SSRIs and suicidality: a systematic longitudinal study. BMJ Open. 2011;1(2):e000290.
  • Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and Abuse. cited 2018 Mar 10. Available from: https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm338566.htm
  • Chang J, Jordan BG, Chong W, et al. Reading tea leaves: how humans interpret topic models. Advances in Neural Information Processing Systems; 2009. p. 288–296.
  • Lee S, Song J, Kim Y. An empirical comparison of four text mining methods. J Comput Inf Syst. 2010;51(1):1–10.
  • Harpaz R, Callahan A, Tamang S, et al. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014;37(10):777–790.
  • Gurulingappa H, Klinger R, Hofmann-Apitius M, et al. An empirical evaluation of resources for the identification of diseases and adverse effects in biomedical literature. 2nd Workshop on Building and Evaluating Resources for Biomedical Text Mining (7th edition of the Language Resources and Evaluation Conference); 2010. p. 15–22.
  • Gurulingappa H, Rajput AM, Roberts A, et al. Development of a benchmark corpus to support the automatic extraction of drug-related adverse effects from medical case reports. J Biomed Inform. 2012;45(5):885–892.
  • Van Mulligen EM, Fourrier-Reglat A, Gurwitz D, et al. The EU-ADR corpus: annotated drugs, diseases, targets, and their relationships. J Biomed Inform. 2012;45(5):879–884.
  • Li DC, Rastegar-Mojarad M, Okamoto J, et al. A bibliometric analysis on cancer population science with topic modeling. AMIA Jt Summits Transl Sci Proc. 2015;2015:102–106.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.